-
公开(公告)号:US11629171B2
公开(公告)日:2023-04-18
申请号:US16762394
申请日:2018-11-12
申请人: POLYPHOR AG
发明人: Daniel Obrecht , Anatol Luther , Francesca Bernardini , Glenn E. Dale , Nicolas Desjonqueres , Emile Brabet , Grégory Upert
摘要: Beta-hairpin peptidomimetics of the general formula (I), and pharmaceutically acceptable salts thereof, with P, X, Q., and optionally L being elements as defined in the description and the claims, have Gram-negative antimicrobial activity to e.g. inhibit the growth or to kill microorganisms such as Klebsiella pneumoniae and/or Acinetobacter baumannii and/or Escherichia coli and/or Pseudomonas aeruginosa and/or Enterobacter cloacae. They can be used as medicaments to treat or prevent infections or as disinfectants for foodstuffs, cosmetics, medicaments or other nutrient-containing materials. These peptidomimetics can be manufactured by a process which is based on a mixed solid- and solution phase synthetic strategy.
-
公开(公告)号:US10730911B2
公开(公告)日:2020-08-04
申请号:US15564539
申请日:2016-04-06
申请人: POLYPHOR AG , Universität Zürich
发明人: Daniel Obrecht , Christian Bisang , Anatol Luther , Steffen Weinbrenner , John Anthony Robinson , Kerstin Moehle , Christian Steuer , William J. Drury, III
IPC分类号: A61K38/08 , A61K38/12 , C07K7/54 , C07K7/64 , C07K14/72 , A61K38/02 , C07K1/04 , C07K14/00 , C07K14/47 , C07K14/655 , C07K14/705 , C40B50/14 , A61K38/00
摘要: Novel backbone-cyclized peptidomimetics of the general formula cyclo[-P1-P2-P3-P4-P5-P6-P7-P8-T1-T2-] (I) wherein the single elements T or P are α-amino acid residues connected in either direction which, depending on their positions in the chain, are as defined in the description and the claims, and salts thereof, have the property to modulate the GLP-1 receptor. They can be used as medicaments to treat, prevent, or delay the onset of diseases, disorders or conditions in which modulation of the human GLP-1 receptor is beneficial, such as type 2 diabetes. These backbone-cyclized peptidomimetics can be manufactured by a process which is based on a mixed solid—and solution phase synthetic strategy.
-
公开(公告)号:US10654897B2
公开(公告)日:2020-05-19
申请号:US15515417
申请日:2015-09-29
申请人: POLYPHOR AG
发明人: Daniel Obrecht , Anatol Luther , Francesca Bernardini , Peter Zbinden , Sophie Barthelemy , Alexander Lederer
摘要: Beta-hairpin peptidomimetics of the general formula (I), cyclo[P1-P2-P3-P4-P5-P6-P7-P8-P9-P10-P11-P12-T1-T2] and pharmaceutically acceptable salts thereof, with P1 to P12, T1 and T2 being elements as defined in the description and the claims, have Gramnegative antimicrobial activity to e.g. inhibit the growth or to kill microorganisms such as Klebsiella pneumoniae and/or Acinetobacter baumannii and/or Escherichia coli. They can be used as medicaments to treat or prevent infections or as disinfectants for foodstuffs, cosmetics, medicaments or other nutrient-containing materials. These peptidomimetics can be manufactured by a process which is based on a mixed solid- and solution phase synthetic strategy.
-
公开(公告)号:US09775877B2
公开(公告)日:2017-10-03
申请号:US14419986
申请日:2013-08-07
申请人: POLYPHOR AG
CPC分类号: A61K38/12 , A61K31/65 , A61K38/10 , A61K47/6809 , A61L2300/406 , C07K7/08 , C07K7/50 , C07K7/64 , A61K2300/00
摘要: A novel combination comprising a β-hairpin peptidomimetic of the formula cyclo(-Thr-Trp-Ile-Dab-Orn-DDab-Dab-Trp-Dab-Dab-Ala-Ser-DPro-Pro) (I), and a compound of the glycylcycline class, especially tigecycline, that enable therapeutic control of specific bacterial infections in human or animals at doses of the individual compounds lower than either of the compounds administered alone. The combination can be used as a medicament to treat e.g. skin or soft tissue infections; eye, ear, blood stream, or intra-abdominal infections; infections related to respiratory diseases, to bone diseases, to cardiovascular diseases, to genitourinal diseases, or to gastrointestinal diseases.
-
公开(公告)号:US10370412B2
公开(公告)日:2019-08-06
申请号:US15816955
申请日:2017-11-17
申请人: Polyphor AG
摘要: Beta-hairpin peptidomimetics of the general formula (I), cyclo[P1—P2—P3—P4—P5—P6—P7—P8—P9—P10—P11—P12-T1-T2], and pharmaceutically acceptable salts thereof, with P1 to P12, T1 and T2 being elements as defined in the description and the claims, have broad spectrum Gram-negative antimicrobial activity to e.g. inhibit the growth or to kill microorganisms such as Klebsiella pneumoniae and/or Acinetobacter baumannii and/or Escherichia coli. They can be used as medicaments to treat or prevent infections or as disinfectants for foodstuffs, cosmetics, medicaments or other nutrient-containing materials.These peptidomimetics can be manufactured by a process which is based on a mixed solid- and solution phase synthetic strategy.
-
公开(公告)号:US10363284B2
公开(公告)日:2019-07-30
申请号:US15444045
申请日:2017-02-27
申请人: POLYPHOR AG
摘要: β-Hairpin peptidomimetics of the general formula cyclo(-Tyr1-His2-Xaa3-Cys4-Ser5-Xaa6-DPro7-Xaa8-Arg9-Tyr10-Cys11-Tyr12-Xaa13-Xaa14-Xaa15-Pro16-), disulfide bond between Cys4 and Cys11, and pharmaceutically acceptable salts thereof, with Xaa3, Xaa6, Xaa8, Xaa13, Xaa14 and Xaa15 being amino acid residues of certain types which are defined in the description and the claims, have favorable pharmacological properties and can be used for preventing HIV infections in healthy individuals or for slowing and halting viral progression in infected patients; or where cancer is mediated or resulting from CXCR4 receptor activity; or where immunological diseases are mediated or resulting from CXCR4 receptor activity; or for treating immunosuppression; or during apheresis collections of peripheral blood stem cells and/or as agents to induce mobilization of stem cells to regulate tissue repair.These peptidomimetics can be manufactured by a process which is based on a mixed solid- and solution phase synthetic strategy.
-
公开(公告)号:US10273267B2
公开(公告)日:2019-04-30
申请号:US15107575
申请日:2013-12-27
申请人: POLYPHOR AG
发明人: Frank Otto Gombert , Daniel Obrecht , Odile Sellier-Kessler , Alexander Lederer , Christian Ludin , Manuella Schmitt-Billet , Steffen Weinbrenner
摘要: β-Hairpin peptidomimetics of the general formula cyclo(-Xaa1-Xaa2-Thr3-Xaa4-Ser5-Xaa6-Xaa7-Xaa8-Xaa9-Xaa10-Xaa11-Xaa12-Xaa13-) and pharmaceutically acceptable salts thereof, with Xaa1, Xaa2, Xaa4, Xaa6, Xaa7, Xaa8, Xaa9, Xaa10, Xaa11, Xaa12 and Xaa13 being amino acid residues of certain types which are defined in the description and the claims, have elastase inhibitory properties, especially against human neutrophil elastase, and can be used for preventing infections or diseases related to such infections in healthy individuals or for slowing infections in infected patients. The compounds of the invention can further be used where cancer, or immunological diseases, or pulmonary diseases, or cardiovascular diseases, or neurodegenerative diseases, or inflammation, or diseases related to inflammation, are mediated or resulting from elastase activity. These peptidomimetics can be manufactured by a process which is based on a mixed solid- and solution phase synthetic strategy.
-
公开(公告)号:US09938322B2
公开(公告)日:2018-04-10
申请号:US14781247
申请日:2014-03-28
申请人: POLYPHOR AG
CPC分类号: C07K7/64 , A61K38/00 , C07K7/08 , Y02A50/473
摘要: Beta-hairpin peptidomimetics of the general formula (I), cyclo[P1-p2-p3-p4-p5-p6-p7-p8-p9-p10-p11-p12-T1-T2], and pharmaceutically acceptable salts thereof, with P1 to P12, T1 and T2 being elements as defined in the description and the claims, have Gram-negative antimicrobial activity to e.g. inhibit the growth or to kill microorganisms such as Klebsiella pneumoniae and/or Acinetobacter baumannii and/or Escherichia coli. They can be used as medicaments to treat or prevent infections or as disinfectants for foodstuffs, cosmetics, medicaments or other nutrient-containing materials. These peptidomimetics can be manufactured by a process which is based on a mixed solid- and solution phase synthetic strategy.
-
公开(公告)号:US09957297B2
公开(公告)日:2018-05-01
申请号:US14349683
申请日:2012-10-02
申请人: POLYPHOR AG
发明人: Françoise Jung , Daniel Obrecht , Ralf Löwe , Johann Zimmermann , Guillaume Lemercier , Eric Chevalier
IPC分类号: A61K38/00 , C07K14/47 , A01N37/18 , A61P31/04 , A61P23/00 , A61P17/00 , A61P29/00 , A61P35/00 , A61K38/10 , A61K38/12 , C07K5/00 , C07K7/00 , C07K16/00 , C07K17/00 , C07K1/00 , C07K7/08 , C07K7/64
摘要: Novel template-fixed β-hairpin peptidomimetics of the general formula (I): cyclo[P1-P2-P3-P4-P5-P6-P7-P8-P9-P10-P11-P12-P13-P14-T1-T2] wherein the single elements T or P are α-amino acid residues connected in either direction which, depending on their positions in the chain, are as defined in the description and the claims, and salts thereof, have the property of antagonizing the biological effect of the receptor FPR1. They can be used as medicaments to treat or prevent diseases or conditions in the areas of inflammatory diseases, allergic conditions, immunological disorders, neuroinflammation, neurological disorders, obstructive airway diseases, infectious diseases, ischemic reperfusion injuries and proliferative disorders such as e.g. cancer. These β-hairpin peptidomimetics can be manufactured by a process which is based on a mixed solid- and solution phase synthetic strategy.
-
公开(公告)号:US09637520B2
公开(公告)日:2017-05-02
申请号:US14795694
申请日:2015-07-09
申请人: POLYPHOR AG
发明人: Frank Otto Gombert , Alexander Lederer , Ralf Löwe , Daniel Obrecht , Barbara Romagnoli , Johann Zimmermann , Kalpana Patel
IPC分类号: C07K7/64 , A61K38/12 , C07K14/715 , C07K14/705 , A61K38/00 , A61K38/17
CPC分类号: C07K7/64 , A61K38/00 , A61K38/17 , A61K38/177 , A61K38/1793 , C07K14/705 , C07K14/715 , C07K14/7158
摘要: Novel template-fixed β-hairpin peptidomimetics of the general formula (I) wherein the single elements T or P are α-amino acid residues connected from the carbonyl (C═O) point of attachment to the nitrogen (N) of the next element in clockwise direction and wherein said elements, depending on their positions in the chain, are defined in the description and the claims have the property to act on the receptor CXCR7. Thus, these β-hairpin peptidomimetics can be useful in the treatment or prevention of diseases or conditions in the area of dermatological disorders, metabolic diseases, inflammatory diseases, fibrotic diseases, infectious diseases, neurological diseases, cardiovascular diseases, respiratory diseases, gastro-intestinal tract disorders, urological diseases, ophthalmic diseases, stomatological diseases, haematological diseases and cancer; or the mobilization of stem cells.
-
-
-
-
-
-
-
-
-